about
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis BAn integrated approach in the discovery and characterization of a novel nuclear protein over-expressed in liver and pancreatic tumorsInsight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liverUnderexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinomaThe Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomasCommon Variants of the Prostaglandin-Endoperoxide Synthase 2 Gene and Hepatocellular Carcinoma SusceptibilityOverexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosisGenes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinomaGene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinomaStructural and functional characterization of a monoclonal antibody specific for the preS1 region of hepatitis B virusMutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomasPromoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinomaHcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinomaCyclophilin J is a novel peptidyl-prolyl isomerase and target for repressing the growth of hepatocellular carcinomaThe global epidemiology of hepatocellular carcinoma: present and futureMolecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma.The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK.Radiofrequence ablation of liver cancers.Proteome analysis of a human heptocellular carcinoma cell line, HCC-M: an update.Mechanisms of nitric oxide-induced cytotoxicity in normal human hepatocytes.The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996.Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-upGlobal proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion.Targeting specificity and pharmacokinetics of asialoorosomucoid, a specific ligand for asialglycoprotein receptor on hepatocyte.Hospice palliative care for patients with hepatocellular carcinoma in Taiwan.Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using (18)F-FDG PET/CT and (99m)Tc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation.Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma modelLiver transplantation and cirrhotomimetic hepatocellular carcinoma: classification and outcomes.The woodchuck model of hepatitis B virus infection.Metabolic restaging of hepatocellular carcinoma using whole-body F-FDG PET/CT.Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.Immunotherapy of hepatocellular carcinoma.Non-surgical treatment of hepatocellular carcinoma.Attitudes and beliefs about hepatitis B vaccination among gay men: the Birmingham Measurement Study.Tumor vaccine against recurrence of hepatocellular carcinoma.Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.Clinical and virological responses to clevudine therapy of hepatocelluar carcinoma patients with chronic hepatitis B.S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry.Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
P2860
Q24248748-438365D4-AFED-4AAB-8742-B753224299D9Q24291237-35908DA1-7263-48DE-9FF9-55B236E558F4Q24555051-1088B40B-DD13-43AC-BC8D-C391BC2D05C2Q24648832-F9B900D5-2B31-4F85-9DB6-EA02291BFFF7Q24681487-6828A08B-869F-4056-AA92-EF4E3DB6EA8EQ26786180-28F20429-7F6B-42F2-874F-BCFAE9B4A869Q27310338-46A5D0F8-53CB-4A70-A0DA-B826E654068BQ27487515-E704100F-71BE-4EE3-8D71-7DA06B930F0FQ27490242-2A4109D4-AA9F-4C03-9CC6-B8401E1E47FDQ27636951-A17A3EA4-A97F-4F27-AF6D-CBF8C1376483Q28213290-5D43F2E6-FE4F-4B39-9B72-ABB6E54387B5Q28265788-EB6807FA-F180-4BA9-BC02-5DE1852B80B2Q28304534-C29D6748-909F-4EDB-8ED9-5989543A64EBQ28547553-739608C8-415D-4CA7-8F41-6FD919E09FEBQ28654353-BB8166DD-E5D2-4437-A2CC-47723777C1F8Q30165307-110CCD47-1C48-468B-B6DA-A9F88A54723FQ30167985-5ED0FF08-6A10-4161-A341-B5653724DC72Q30396930-8CDD76DE-9960-452C-B9E5-F6CE0A4875C9Q30712249-B495C91D-5B18-462E-A3DC-BE33E92C4B9CQ31913532-AE5CCB15-99C1-4181-B604-3CDFE8474F15Q33179763-6BC34DF0-9745-4C33-AD3A-D4D99E6BD3A7Q33208819-7566FAE1-23A0-44D3-923E-10E8130B1BB0Q33250475-9F690FE6-E7D5-475A-BA3E-5A3D1DA27BA7Q33285978-1155AD97-35D3-47D9-8E61-CC2939D6ED5DQ33360149-AD9E4514-9CFD-404D-8658-CD5D8FA4B771Q33704392-53EC0062-B6EE-4766-895E-BC826A440C01Q34093354-C62B4ABA-9D35-47D5-85E8-81924F19EE40Q34096867-DF481170-499C-4A75-8138-4731EBB33344Q34282796-8A5A2B82-7C3C-4A00-A59A-6A4CF679A97AQ34390224-381BBE63-ADF0-4AD9-8770-3F326785560FQ34528429-DEB58E0E-A533-4CC4-BC84-ED0E041E1D95Q34534264-2E98405B-6B4A-45E0-A9B2-3CBABF2636D6Q34539241-1D9A4DC8-A0DC-41BB-8974-095F8D6D21E8Q34598883-E2A1963F-1FA3-44CF-87D3-DEF359CF549FQ34605421-08722DE9-F98E-43CD-B078-0893950DE769Q34632966-1DC66513-8870-4AD7-9A5B-16813A8AF3F7Q34725898-8EBB4E16-55DF-4229-AB9B-2610BD158D6AQ34778723-734A572B-A648-49B6-85F2-380BEF07BF78Q34802516-39DBC388-0CDB-4F21-B8F6-6537CD36407DQ34850055-7A93B086-101E-4DA5-92B0-C03CB5D68C1D
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Hepatocellular carcinoma.
@ast
Hepatocellular carcinoma.
@en
type
label
Hepatocellular carcinoma.
@ast
Hepatocellular carcinoma.
@en
prefLabel
Hepatocellular carcinoma.
@ast
Hepatocellular carcinoma.
@en
P1433
P1476
Hepatocellular carcinoma.
@en
P2093
D F Schafer
M F Sorrell
P304
P356
10.1016/S0140-6736(98)09148-X
P407
P577
1999-04-01T00:00:00Z